ICOSAVAX, INC. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/34a46d95-41a8-4995-bd00-07caa7d156bf/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $582.0k | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010983 |
| FY 2021 | $7.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-005064 |
| FY 2020 | $1.6M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-005064 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).